Revenue

Zillow details its ambitious AI-native platform, promising to reshape the home buying journey from search to close while setting bold new financial targets.

With 35+ years of orthopedic sales experience, Thurman Ballard joins Tetrous to drive adoption of its groundbreaking bone-to-tendon healing technology.

Amid soaring prices and geopolitical turmoil, Australian firm Llyodstern launches Petro-Insight, an AI platform aiming to bring clarity to a volatile market.

LiviWell's Livi device, the first of its kind, gets FDA clearance to absorb post-sex fluids, aiming to improve comfort and vaginal health.

With AI automating code, a new startup says the real challenge is planning. Backed by Menlo Ventures, BrainGrid is building the tools for non-coders.

After 22 years, seed-based snack pioneer Go Raw launches its first national campaign, using humor to fight snack aisle confusion and bet big on simplicity.

Beyond record profits, Sonepar's 2025 results show how digital transformation and strategic acquisitions are powering the global shift to electricity.

GuideWell's 2025 Impact Report details a multi-pronged strategy using AI, community investment, and value-based care to tackle healthcare costs.

A new $1.35M program seeks to validate diagnostic tests for Long COVID, paving the way for targeted treatments and offering hope to millions.

With new financing from Avenue Capital, Turn Therapeutics bets big on its novel skin therapy, GX-03, to tackle multi-billion dollar dermatology markets.

Artis BioSolutions is opening a new synthetic DNA facility in Boston, aiming to reduce supply chain risks and accelerate next-gen medicine development.

New research shows larger AI models aren't always safer for coding, revealing that real-time data is the key to securing the software supply chain.

With new funding from Innovation Endeavors and YC, Conduit aims to replace spreadsheets and manual chaos with an AI-powered platform for dock operations.

Capstone Holding Corp. merges Midwest operations, targeting positive EBITDA by 2026 amid major project wins and a disciplined cost-cutting campaign.

New data reveals marketing contributes $130.9B to Canada's GDP, rivaling major industries and creating high-paying jobs while raising new policy questions.

An Australian tech firm has launched a new data suite using AI and alternative data to predict and navigate the chaotic semiconductor supply chain.

A US-Japan biotech firm secures major funding to advance a first-in-class drug, offering new hope for millions with inherited blood disorders.

With a historic investment doubling its FSC-certified teak, AdvantageLumber.com aims to solve supply chain woes and dominate the sustainable luxury wood market.

A new alliance between Discovery Life Sciences and Mindpeak aims to solve inconsistent biomarker interpretation, a critical bottleneck in cancer drug development.

The infrastructure distributor overcame a mixed Q4 to deliver full-year growth, reducing debt and outlining a clear strategy for expansion and share gains.